Home / Inspections / 1106449

FDA Inspection 1106449 — Eurofins Lancaster Laboratories, LLC

Eurofins Lancaster Laboratories, LLC — FEI 2513291

The FDA completed an inspection of Eurofins Lancaster Laboratories, LLC on September 13, 2019 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 13, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Lancaster, PA (United States)

Facility

Other inspections at this facility

  • 1284580 (NAI Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1279557 (VAI Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1156933 (NAI Thu Oct 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113269 (NAI Thu Oct 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1029560 (NAI Thu Sep 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources